Cost-effectiveness of ampicillin/sulbactam versus cefoxitin in the treatment of pelvic inflammatory disease

Michael A. Wynd, David L. Hemsell, Joseph A. Paladino

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'Cost-effectiveness of ampicillin/sulbactam versus cefoxitin in the treatment of pelvic inflammatory disease'. Together they form a unique fingerprint.

Medicine & Life Sciences